Harbor Health Care ETF (MEDI)
MEDI
New York Stock Exchange Arca- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Harbor Health Care ETF (MEDI) is an actively managed exchange-traded fund that seeks long-term capital growth by investing primarily in equity securities of companies engaged in the health care sector worldwide; it focuses on a concentrated portfolio of 30 to 50 quality growth-oriented stocks selected for their differentiated products, technologies, and services in areas such as targeted oncology, gene therapy, orphan diseases, medical devices, biotechnology, and health care services. The fund employs fundamental analysis and bottom-up stock picking by its subadviser, Westfield Capital Management Company, L.P., targeting companies positioned to benefit from secular growth and innovation in the U.S. and global health care systems while adhering to disciplined valuation criteria; top holdings typically include firms like Ascendis Pharma, Eli Lilly, UnitedHealth Group, Legend Biotech, and AbbVie, with substantial allocations to biotechnology, pharmaceuticals, and health care providers. Issued by Harbor ETF Trust and advised by Harbor Capital Advisors, Inc., MEDI benchmarks against the Russell 3000 Growth Health Care Index and features a net expense ratio of 0.80%, with assets under management around $20 million. Launched on November 16, 2022, and listed on NYSE Arca, the ETF is headquartered in Chicago, Illinois, through its adviser Harbor Capital Advisors, Inc., with subadvisory support from Boston-based Westfield Capital Management. Geographically, MEDI provides exposure to U.S. and non-U.S. health care companies, including developed and emerging markets, with approximately 75% in U.S. stocks and 24% in non-U.S. equities as of recent data. In late 2025, Harbor Capital celebrated the ETF's three-year anniversary, highlighting its strong performance and five-star Morningstar rating in the U.S. Fund Health category, underscoring its evolution as a differentiated active health care allocation strategy amid sector innovation and value-based care trends. No major acquisitions, funding rounds, or strategic alliances specific to MEDI were reported in the last 1-2 years, though the fund continues to adapt its concentrated portfolio to capitalize on health care disruptions.